Board of directors

Etienne Jornod

Etienne Jornod

Executive Chairman

Etienne Jornod

Etienne Jornod

Executive Chairman

  • Born 1953, Swiss citizen
  • Lic. oec., HEC University of Lausanne/Senior Executive Program, Stanford University (USA)
  • Joined the Group in 1975 as a Junior Product Manager; left the Group in 1978; returned in 1981 (after obtaining a university degree) as Assistant to the Corporate Executive Committee; joined the Corporate Executive Committee in 1989; Chairman of the Board of Directors and CEO of Galenica from 1996 to 2011; Executive Chairman since 2012
  • Chairman of the Board of Directors of the Aktiengesellschaft für die Neue Zürcher Zeitung (Zurich) and member of the Board of Directors of Vaudoise Assurances Holding SA (Lausanne)

Daniela Bosshardt-Hengartner

Daniela Bosshardt-Hengartner

Daniela Bosshardt-Hengartner

Daniela Bosshardt-Hengartner

  • Born 1972, Swiss citizen
  • Pharmacist, Federal Diploma in Pharmacy, Federal Institute of Technology, Zurich
  • Financial analyst at Bank am Bellevue (1998–2002) and M2 Capital (2003–2004)
  • Management consultant in the pharmaceutical, medical technology and biotechnology sectors since 2004
  • Member of the Board of Directors of RepRisk AG (Zurich)
Prof. Dr. Michel Burnier

Prof. Dr. Michel Burnier

Prof. Dr. Michel Burnier

Prof. Dr. Michel Burnier

  • Born 1953, Swiss citizen
  • Swiss-registered Doctor of Internal Medicine and Nephrology
  • University Lecturer, University of Lausanne
  • Formerly a member of the Medicines Committee of the Swiss Association of Pharmacists (until 2001), the Board of Swissmedic (2002–2010) and the Board of Directors of Speedel Holding Ltd. (2007–2009)
  • Member of the following organisations: Swiss Society of Nephrology (President), Scientific Council of the European Society of Hypertension (Treasurer) and Swiss Society of Hypertension (President)

Dr. Romeo Cerutti

Dr. Romeo Cerutti

Dr. Romeo Cerutti

Dr. Romeo Cerutti

  • Born 1962, Swiss and Italian citizen
  • Doctor of Law, Law studies at the University of Fribourg, Switzerland; Master of Laws from the University of California, School of Law, Los Angeles
  • Attorney-at-law with Latham and Watkins (1993–1995) and Homburger Rechtsanwälte (1995–1999)
  • Head of Corporate Finance at Lombard Odier Darier Hentsch & Cie (1999–2006) and partner of the Group Holding of Lombard Odier Darier Hentsch & Cie (2004–2006)
  • General Counsel of the Private Banking division Credit Suisse (2006–2009)
  • General Counsel and a member of the Executive Board of Credit Suisse Group Ltd. and Credit Suisse Ltd. since April 2009
  • Member of the Board of Trustees of the University of Fribourg since 2006
Marc de Garidel

Marc de Garidel

Marc de Garidel

Marc de Garidel

  • Born 1958, French citizen
  • Master in Engineering, Ecole Supérieure des Travaux Publics, Paris; Master in International Management, Thunderbird School of Management, Phoenix (USA); Executive Master in Business Administration, Harvard University, Boston (USA)
  • Various positions at Lilly, most recently as finance director Germany (1983–1995)
  • Various positions at Amgen, including Vice-President Finance and Administration Europe, Vice-President and Chief Administration Officer, and General Manager for France and Vice-President of the South International Region (1995–2010)
  • Since 2010 Chairman of the Board of Directors and CEO of Ipsen

Dr. Sylvie Grégoire

Dr. Sylvie Grégoire

Dr. Sylvie Grégoire

Dr. Sylvie Grégoire

  • Born 1961, Canadian and US citizen
  • Dr. pharm., State University of New York in Buffalo (NY/USA), pharmacy degree from Université Laval, Quebec City (Canada)
  • Formerly President of Shire Human Genetic Therapies (2007–2013), worked in various roles at companies including Merck & Company (1987–1995), Biogen Inc. (1995–2003), GlycoFi Inc. (2004–2005) and IDM Pharma (2006–2007)
  • Advisor to venture capital and biotech companies
  • Former member of the Boards of Directors of various companies in the USA and Canada, and the boards of various charitable organisations
  • Member of the Board of Directors of Novo Nordisk and PerkinElmer Inc.
Fritz Hirsbrunner

Fritz Hirsbrunner

Fritz Hirsbrunner

Fritz Hirsbrunner

  • Born 1949, Swiss citizen
  • Lic. oec., HEC University of Lausanne/Senior Executive Program, IMD, Lausanne
  • 1972–1977 Controller at Ciba-Geigy
  • Joined the Galenica Group in 1977 as Assistant to the Corporate Executive Committee; member of the Corporate Executive Committee from 1992 to 2011; Deputy CEO and CFO; Head Investor Relations until February 2014
  • Member of the Board of Directors of Berlac AG, Sissach, and IVF Hartmann Holding AG, Neuhausen
  • Member of the Board of Trustees of IST Investmentstiftung für Personalvorsorge, Zurich
  • Member of the Board of Directors of VenCap 6 Ltd., Jersey

Stefano Pessina

Stefano Pessina

Stefano Pessina

Stefano Pessina

  • Born 1941, citizen of Monaco
  • Nuclear engineering degree, Milan Polytechnic
  • Former management consultant, active as an entrepreneur in various pharmaceutical distribution companies since 1976; became Deputy Chairman in 1997, and CEO between 2001 and 2006 of Alliance UniChem Plc, Weybridge (UK); since 2007 Executive Chairman of Alliance Boots, London (UK) and Executive Vice Chairman of the Board and Chief Executive Officer of Walgreens Boots Alliance, Inc., having been appointed to the Board of Walgreens in 2012
This E. Schneider

This E. Schneider

Vice-Chairman

This E. Schneider

This E. Schneider

Vice-Chairman

  • Born 1952, Swiss citizen
  • Lic. oec., HSG University of St. Gallen/Graduate School of Business, Stanford University (USA)
  • Previously held various managerial positions in Europe and in the USA, at SAFAA (1991–1993), Valora (1994–1997) and Selecta Group (1997–2002). From 2004 until March 2014, Delegate of the Board of Directors and CEO of Forbo International AG, Baar, since April 2014 Executive Chairman of Forbo International AG, Baar
  • Rieter Holding AG, Winterthur (Vice-Chairman of the Board of Directors), Antoneum Holding AG, Winterthur (member of the Board of Directors)

Contact

Galenica Ltd.

Untermattweg 8
CH-3027 Bern

Phone:
+41 58 852 81 11
Fax:
+41 58 852 81 12

Send link

Send as link



Links

  •